These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 16602113

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Novel LRRK2 mutations in Parkinsonism.
    Trinh J, Guella I, McKenzie M, Gustavsson EK, Szu-Tu C, Petersen MS, Rajput A, Rajput AH, McKeown M, Jeon BS, Aasly JO, Bardien S, Farrer MJ.
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1119-21. PubMed ID: 26213354
    [No Abstract] [Full Text] [Related]

  • 8. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN, Wang Y, Karlins E, Saito L, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K.
    Neurology; 2006 Nov 28; 67(10):1786-91. PubMed ID: 17050822
    [Abstract] [Full Text] [Related]

  • 9. [Clinical features of LRRK2-associated Parkinson's disease].
    Pchelina SN, Ivanova ON, Emel'ianov AK, Iakimovskiĭ AF.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011 Nov 28; 111(12):56-62. PubMed ID: 22433811
    [Abstract] [Full Text] [Related]

  • 10. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN, Shadrina MI, Slominsky PA, Bespalova EV, Zagorovskaya TB, Bagyeva GKh, Markova ED, Limborska SA, Ivanova-Smolenskaya IA.
    Eur J Neurol; 2007 Apr 28; 14(4):413-7. PubMed ID: 17388990
    [Abstract] [Full Text] [Related]

  • 11. Genetic screening for two LRRK2 mutations in French patients with idiopathic Parkinson's disease.
    Funalot B, Nichols WC, Pérez-Tur J, Mercier G, Lucotte G.
    Genet Test; 2006 Apr 28; 10(4):290-3. PubMed ID: 17253937
    [Abstract] [Full Text] [Related]

  • 12. Genetic screening for the LRRK2 R1441C and G2019S mutations in Parkinsonian patients from Campania.
    De Rosa A, De Michele G, Guacci A, Carbone R, Lieto M, Peluso S, Picillo M, Barone P, Salemi F, Laiso A, Saccà F, Tessitore A, Pellecchia MT, Bonifati V, Criscuolo C.
    J Parkinsons Dis; 2014 Apr 28; 4(1):123-8. PubMed ID: 24496098
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.
    Gaig C, Ezquerra M, Marti MJ, Muñoz E, Valldeoriola F, Tolosa E.
    Arch Neurol; 2006 Mar 28; 63(3):377-82. PubMed ID: 16533964
    [Abstract] [Full Text] [Related]

  • 16. Screening for LRRK2 mutations in patients with Parkinson's disease in Russia: identification of a novel LRRK2 variant.
    Pchelina SN, Yakimovskii AF, Emelyanov AK, Ivanova ON, Schwarzman AL, Singleton AB.
    Eur J Neurol; 2008 Jul 28; 15(7):692-6. PubMed ID: 18435766
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.